Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Geovax Labs (NQ: GOVX )

2.720 -0.080 (-2.86%)
Streaming Delayed Price Updated: 1:56 PM EDT, Jul 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 176,396
Open 2.720
Bid (Size) 2.690 (5)
Ask (Size) 2.720 (100)
Prev. Close 2.800
Today's Range 2.600 - 2.750
52wk Range 1.090 - 10.24
Shares Outstanding 2,172,309
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
GeoVax (GOVX) Stock Pops Ahead of July 18 Catalyst
Geovax Labs stock is up on Tuesday as GOVX investors are excited about a potential catalyst for the company's shares on July 18. 
Via InvestorPlace
GeoVax to Present at the Emerging Growth Conference on July 18, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Exposures COVID-19

Performance

YTD
-50.99%
-50.99%
1 Month
+16.74%
+16.74%
3 Month
+75.48%
+75.48%
6 Month
-37.06%
-37.06%
1 Year
-68.26%
-68.26%

More News

Read More
GeoVax to Present at the Emerging Growth Conference on July 18, 2024
Via TheNewswire.com
Exposures COVID-19
GeoVax to Raise Approximately $3.1 Million of Gross Proceeds in Offering Priced At-the-Market
Via NewMediaWire
Topics Regulatory Compliance
Exposures Legal Regulatory
GeoVax to Raise Approximately $3.1 Million of Gross Proceeds in Offering Priced At-the-Market
Via TheNewswire.com
Topics Regulatory Compliance
Exposures Legal Regulatory
GeoVax Provides First Half 2024 Business Update
Via NewMediaWire
(GOVX) - Analyzing Geovax Labs's Short Interest
Via Benzinga
Why Is GeoVax (GOVX) Stock Up 110% Today?
Via InvestorPlace
Exposures COVID-19
Why GeoVax Labs Stock Is Moving Higher Thursday
Via Benzinga
Exposures COVID-19
GeoVax Partners with Allucent to Conduct Phase 2b Clinical Study of Next-Generation COVID-19 Vaccine Candidate with Funding from BARDA
Via NewMediaWire
Exposures COVID-19
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
GeoVax to Present at BIO International Convention 2024
Via TheNewswire.com
Exposures COVID-19
Pancreatic Cancer Market Is Projecting to Expand As NCI-Funded Research Expects to Empower Market Growth
Via FinancialNewsMedia
Topics Death
Exposures Death
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Pancreatic Cancer Market Is Projecting to Expand As NCI-Funded Research Expects to Empower Market Growth
From FN Media Group LLC
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
GeoVax Receives BARDA Project NextGen Award to Conduct Phase 2b Clinical Study Evaluating the Company's Next-Generation COVID-19 Vaccine Candidate, GEO-CM04S1
Via NewMediaWire
Exposures COVID-19
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
GeoVax to Present at BIO International Convention 2024
Via NewMediaWire
Exposures COVID-19
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.